Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 08:40PM GMT
Release Date Price: $26.63 (+5.97%)
Alethia Rene Young
Cantor Fitzgerald & Co., Research Division - Head of Healthcare Research

Hey, everybody. It's Alethia Young. I cover  large-cap, small, mid-cap biotech here at Cantor. Very happy to have Exelixis here with me to round out day 2, saving the best for last.

We have Dr. Mike Morrissey, who is Director, President and CEO of Exelixis. And we'll be doing a fireside chat for 30 minutes and a lot to work through. But Mike can (inaudible) going first, which is 9ER. Surprise, surprise.

Questions & Answers

Alethia Rene Young
Cantor Fitzgerald & Co., Research Division - Head of Healthcare Research

But it's obviously a huge focus. And just -- I want you to just frame what you can for us around some of the new analysis that we'll get and how to think about some of those results relative to the competition?

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Yes. For sure. Well, thanks again for having us. We've had a great day meeting with investors at your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot